PMID: 19124053

McDevitt CA, Collins R, Kerr ID, Callaghan R
Purification and structural analyses of ABCG2.
Adv Drug Deliv Rev. 2009 Jan 31;61(1):57-65. Epub 2008 Dec 13., 2009-01-31 [PubMed]
Sentences
No. Mutations Sentence Comment
717 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:717:71
status: NEW
view ABCG2 p.Arg482Gly details
Perhaps the most significant variation in pharmacology arises with the R482G mutation, which dramatically alters the substrate specificity of ABCG2 and may provide clues into the site of drug interaction on theprotein [18,19]. Login to comment
722 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:722:50
status: NEW
view ABCG2 p.Arg482Gly details
The substrate specificities for the wild-type and R482G isoforms have been reasonably well characterised with respect to drug transport and the ability to confer resistance [3,19]. Login to comment
725 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 19124053:725:395
status: NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 19124053:725:753
status: NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:725:135
status: NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:725:224
status: NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:725:438
status: NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:725:700
status: NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:725:805
status: NEW
view ABCG2 p.Arg482Gly details
Table 1 Investigations reporting ATPase activity of various ABCG2 isoforms Isoform ATPase activity Drug effect Reference Vmax Km (ATP) R482G (B) 45 nmol min-1 mg-1 - Prazosin IC50 =5 μM [61] Vi inhibits at 50 μM R482G (B) 15 nmol min-1 mg-1 - [21] (S) 32 nmol min-1 mg-1 WT (B) 27 nmol min-1 mg-1 (S) 29 nmol min-1 mg-1 WT (pure) (B) 357 nmol min-1 mg-1 2 mM Vi inhibits 60-80% [20] R482T (pure) (B) 1111 nmol min-1 mg-1 1 mM R482G (B) 10 nmol min-1 mg-1 Stimulated activity at 100 μM prazosin [57] (S) 30 nmol min-1 mg-1 WT (B) 40 nmol min-1 mg-1 - Activities are Vi sensitive [19] (S) 41 nmol min-1 mg-1 Activities reported at a fixed [ATP] and not full Michaelis-Menten analysis R482G (B) 65 nmol min-1 mg-1 (S) 140 nmol min-1 mg-1 R482T (B) 42 nmol min-1 mg-1 (S) 81 nmol min-1 mg-1 R482G (B) 70 nmol min-1 mg-1 - Prazosin IC50 =1 μM and fold-stimulation was 2X [30] (S) 150 nmol min-1 mg-1 The Michaelis-Menten characteristics for ATPase activity by a number of isoforms of ABCG2 are tabulated from a number of source references. Login to comment
732 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:732:14
status: NEW
view ABCG2 p.Arg482Gly details
Wild-type and R482G ABCG2 isoforms are capable of ATP hydrolysis in the absence of any substrate although the Vmax for hydrolysis of 30-50 nmol Pi min-1 mg-1 is considerably lower than that shown for ABCB1. Login to comment
733 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:733:93
status: NEW
view ABCG2 p.Arg482Gly details
The most pronounced stimulation of ATP hydrolysis by substrate has been demonstrated for the R482G mutant in the presence of micromolar concentrations of prazosin. Login to comment
734 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:734:11
status: NEW
view ABCG2 p.Arg482Gly details
Unlike the R482G isoform, the wild-type protein was insensitive to stimulation by many drugs and increased nucleotide trapping in the presence of substrates could not be demonstrated [19]. Login to comment
745 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:745:105
status: NEW
view ABCG2 p.Arg482Gly details
For example, mitoxantrone was more efficient at displacing [125 I]-IAA-Rh123 binding to wild-type versus R482G, but the latter isoform was able to confer greater levels of resistance to the anticancer drug. Login to comment
747 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:747:48
status: NEW
view ABCG2 p.Arg482Gly details
An equilibrium and kinetic binding study on the R482G isoform of ABCG2 revealed the presence of multiple drug interaction sites on the protein [23]. Login to comment
760 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 19124053:760:81
status: NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:760:74
status: NEW
view ABCG2 p.Arg482Gly details
The first studies of ABCG2, and its pharmacologically differing isoforms (R482G, R482T), were conducted in drug selected mammalian cell lines due to the relative simplicity of inducing its expression by drug treatment [26,27]. Login to comment
768 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:768:101
status: NEW
view ABCG2 p.Arg482Gly details
Janvilisri and co-workers utilised Lactococcus (L.) lactis as an expression system for wild-type and R482G ABCG2 [28,33] employing the nisin A-induced expression system that had previously been used for the expression of the prokaryotic ABC transporter LmrA [34]. Login to comment
795 ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 19124053:795:126
status: NEW
view ABCG2 p.Arg482Thr details
This study reported a percentage yield of ABCG2 of ~1.3% (membrane protein) and an approximately two fold lower yield for the R482T isoform. Login to comment
800 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:800:89
status: NEW
view ABCG2 p.Arg482Gly details
Despite this lower affinity, a similar yield of ~1% was observed after IMAC for both the R482G isoform and the wild type (unpublished data). Login to comment
864 ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:864:65
status: NEW
view ABCG2 p.Arg482Gly details
A large oligomeric complex (molecular weight of ~600 kDa) of the R482G isoform was identified by Blue-native PAGE and electron microscopy [37]. Login to comment